/Companies

ACON Injectable Investors I

Washington, US · Founded 2021 · Ontario, Canada limited partnership · 1 known investors

Find your way into ACON Injectable Investors I

Sign up to find every way you can get introduced to ACON Injectable Investors I

  • Your email: who you already know at ACON Injectable Investors I, and who your contacts know
  • 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the ACON Injectable Investors I team
  • Your LinkedIn: the connections who can make the intro for you

We rank every route by how warm it is, so you raise on warm intros instead of cold emails.

Founders & leadership

MW
Masumi WaidaNamed on SEC filing
TY
Teresa Y. BernsteinNamed on SEC filing

Board

JK
Jose KnoellManaging Director of the General Partner of the Issuer.

Investors · 1

FMOreportedThe Hague

How we know: funding news · Not right? Tell us

Reported raises · per SEC filings

Form D private placements

$59M disclosed across 1 round · 2021

▶$59MraisedJun 2021 · 3 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • Masumi WaidaExecutive Officer
  • Teresa Y. BernsteinExecutive Officer
  • ALAOF V GenPar, L.L.C.Promoter
  • Jose KnoellExecutive Officer
Offering amount
$74M
Amount sold
$59M
First sale
May 2021
Incorporated
Limited Partnership, Ontario, Canada, 2021
Federal exemptions
06b, 3C, 3C.7
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Frequently asked questions

Who are ACON Injectable Investors I's investors?
ACON Injectable Investors I's investors include FMO.
How much funding has ACON Injectable Investors I raised?
ACON Injectable Investors I has disclosed $59M raised across 1 round.
Where is ACON Injectable Investors I headquartered?
ACON Injectable Investors I is headquartered in Washington, US.